Vioxx, a COX-2 inhibitor, was removed from the market but may have been beneficial for a subset of patients where it slightly raised blood pressure and led to a small increase in events.

“but I think Merck I think it was Merck that was the company that made vioxx there again I don't want to over speak but I think their arrogance and refusal to act in a timely manner resulted in just the loss of of a drug that I think to this day we'd be better off with and without”